- 1
- 0
- 约小于1千字
- 约 33页
- 2023-09-05 发布于江苏
- 举报
乳腺癌的内分泌治疗;乳癌内分泌治疗历史;乳癌内分泌治疗药物;三苯氧胺 TAM (Tamoxifen,他莫昔芬);5;6;7;8;9;;;Generation
First
Second
Third ;高选择性芳香化酶抑制剂;Femara (Letrozole) vs Aminoglutethimide (AG);Femara AG Clinical Benefit (CR+PR+SD=6 个月) %;Femara AG Median Duration of Clinical Benefit (months);Anastrozole (Arimdex) vs Megestrol Acetate in Advanced Breast Cancer Phase III Trials;Survival DataAnastrozole / MA;Femara? ( letrozole ) vs Tamoxifen as First-Line Therapy ;Cross-Over Design916 MBC;Letrozole Tamoxifen Response Rate (%); ;Femara? ( letrozole ) vs Tamoxifen as Pre-Operative Therapy
原创力文档

文档评论(0)